---
standard: ASD-STE100
automated_check: PASSED
asd_review: PENDING
reviewer: null
reviewed_at: null
limitations:
  - Automated checks do not check the complete approved dictionary or grammar rules.
---

# Final change and release handoff

> **BLOCKED: do not release on the available evidence.**
> Action: close the release holds and reassess the selected artifact and target.
> Consequence: production suitability and deployment authorization remain unproven.
> Owner: unknown release owner. Evidence: [release issue inventory](12-final-release-issues-20261027.md#readiness-conditions).

The [user request](evidence/user-input-20261028-final-material-cleanup.txt) authorizes cleanup and asks for final change and release material.
This handoff consolidates the retained assessment. It does not record a new execution or approval.

## Decision and scope

| Item | Current retained conclusion |
| --- | --- |
| Recommendation | `INSUFFICIENT_EVIDENCE`; technical status `BLOCKED`; `can_go: false`. |
| Decision certainty | `0/100`, `UNDETERMINED`, for production suitability. This is not a probability of failure. |
| Source comparison | Main `f025513f696476a9cc8162681410cbd21e029bcb` against final test commit `e0030f5cf920b715f5831faf7df86cb9789b6d0f`. Main is not a confirmed production baseline. |
| Runtime correction | `1b7de4fe5d7db0c7f490a060d4e3b1c441a5c303`. The final commit includes later test changes. |
| Human decisions | Business acceptance, knowledge publication, and deployment authorization remain pending or unrecorded. |

The [release assessment](10-delivery-confidence-20261026.md#current-task-state) gives the scope, scorecard, and evidence limits.
The assessment is source-based. The production artifact and target remain unbound.

## Change and verification

The change addresses portal session renewal, timeout recovery, and session isolation.
The earlier cancellation-loader and late-acquisition defects are closed locally.
The [historical change review](10-change-review.md) and [local corrections](14-issue-baseline-priority-20261028.md#previously-introduced-defects-fixed-locally) retain their boundaries.

| Evidence | Result and limit |
| --- | --- |
| [Complete unit execution](evidence/four-checks-20261027/coverage/test-only-final-2/execution.json) and [source binding](evidence/four-checks-20261027/application-binding.json) | 471 of 471 tests pass across 123 suites. Failures, skips, todos, and runner errors are zero. This is a local result for the bound candidate. |
| [Browser reconciliation](evidence/four-checks-20261027/e2e/reconciliation.json) | 19 passes and eight failures across 27 cases. The original business inventory has 13 passes and six failures. |
| [Behavior traceability](11-behavior-traceability-20261027.md#relationship-evidence) | Seven original criteria link to cases. Three pass selected predicates, three fail, and one is partial. Complete behavioral equivalence is unproved. |
| [Changed-code matrix](09-delivery-coverage-20261026.md#final-code-change-to-test-matrix) | Twelve of twelve changed runtime paths have a direct inspected test chain. This does not prove complete coverage of each path. |
| [Review reconciliation](evidence/claude-coordination-20261027/reconciliation/review.md) | A synthetic replacement-login probe produces a blocking stale dialog. Production reachability is unknown. This later result qualifies earlier review conclusions. |

The [coverage matrices](09-delivery-coverage-20261026.md#final-candidate-coverage-27-october-2026) separately describe criterion-to-case, criterion-to-code, and code-to-case links.
The [canonical cases](06-test-cases.md) define the applicable setup and assertions.
The [failure analysis](11-e2e-failure-risk-20261027.md) retains each failed predicate and comparison limits.

## Actions before release

All owners below are unknown. The [full release inventory](12-final-release-issues-20261027.md) defines closure evidence and additional risks.

1. Bind the selected source, build, dependencies, artifact digest, and served module. Confirm the target configuration and consumers.
2. Verify candidate-specific risks, including stale dialog reachability and the deployed renewal-token contract.
3. Execute recovery and operational checks against the identified artifact and target. Record monitoring, stop conditions, and responsible operators.
4. Resolve the requirement and assertion gaps. Review the residual impact and selected release scope with the business owner.
5. Reassess the evidence and record the authorized deployment decision. Approval alone does not resolve failed or unknown conditions.

Five inherited failures retain the user's P4/S4 backlog direction; they remain failed.
Other failed or diagnostic cases retain their separate dispositions in the [failure inventory](12-final-release-issues-20261027.md#risks-and-exceptions).
The [impact assessment](15-bau-exposure-impact-20261028.md) separates reproduced effects from conditional effects and unknown production exposure.
The [initial report](01-intake.md#problem-description) describes broad production impact qualitatively. It does not measure candidate-specific frequency.

## Reading and cleanup

Start with this handoff, the [issue intake](01-intake.md), and the [evidence index](evidence/index.md).
Use the linked detailed reports for decisions, source identities, case definitions, and retained results.
Earlier assessments describe earlier candidates or scopes. They do not replace the current decision.
The [cleanup record](evidence/cleanup-20261028.json) identifies removed artifacts, recovery revisions, and recovery limits.
